Skip to content

The First Steps pathway for taking control after a diagnosis of Parkinson’s

The First Steps pathway for taking control after a diagnosis of Parkinson’s: a feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14760402
Enrollment
80
Registered
2018-03-29
Start date
2018-02-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease Nervous System Diseases Parkinson's disease

Interventions

Adults with diagnoses of Parkinson's within the previous 12 months, will be invited to attend the program and be offered the opportunity to take part in the research. It will be made clear to individu

Sponsors

Oxford Brookes University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A recent (within 12 months) diagnosis of Parkinson’s disease 2. Above the age of 18 years

Exclusion criteria

Exclusion criteria: 1. Severe depression or psychosis 2. Reduced cognition that would preclude active involvement and capacity to consent to participate 3. Unable to understand English

Design outcomes

Primary

MeasureTime frame
1. Acceptability, assessed using Process Evaluation Questionnaire (view of venue, staff/facilitator, course content, ease of attendance, impact) 2. Demographics (age, gender, ethnicity, socioeconomic status and rural or urban home, employment) 3. Adherence: % of attendance for Day 1 and Day 2 of First Steps Program 4. Eligibility: number of people screened and that match the eligibility criteria 5. Recruitment: rate of eligible participants enrolled onto the study (%), rate of eligible patients that attended First Steps (%) 6. Retention: no. of enrolled patients that completed the 6 month telephone assessment, number of patients that completed the process evaluation questionnaire, number of patients that completed each outcome measure at baseline, 3 months and 6 months 7. Step-wedge trial: differences in onset of programme provision, number of patients who have attended and not attended First Steps per site 8. Fidelity of delivery, assessed using fidelity checklist at delivery of program

Secondary

MeasureTime frame
1. Generic health status is measured by the Euro-QOL (EQ5D-5L) questionnaire at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 2. Anxiety and depression is measured by the Hospital, Anxiety and Depression Scale (HaDs) at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 3. Social participation is measured by the World Health Organisation Disability Assessment Schedule (WHODAS) at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 4. Service use is measured by the modified Client Service Receipt Inventor (modified CSRI) at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 5. Activities of daily living is measured by the Schwab and England (S&E) questionnaire at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 6. Physical activity is measured by the International physical activity questionnaire-short version (IPAQs) at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 7. Diet over the past year is measured by the EPIC-Norfolk Food Frequency Questionnaire. At baseline (0 weeks) a link to an online version of the EPIC questionnaire OR a paper copy is sent by post to the participant to be completed at the participants convenience 8. Diet over the previous day is measured using the 24-hour Food Recall at baseline (0 weeks), three months (12 weeks) and six months (24 weeks) 9. Carer strain is measured by the Caregiver Strain Index at baseline (0 weeks), three months (12 weeks) and six months (24 weeks)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026